The exacerbation component of impairment and risk in pediatric asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 2, 2010, Pages 155-160

  Bloomberg, Gordon R ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Asthma; Children; Exacerbations

Indexed keywords

ALLERGEN;

ASTHMA; ATOPY; CHILD; DISEASE EXACERBATION; EMERGENCY WARD; GENETIC VARIABILITY; HUMAN; LUNG FUNCTION; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS;

ALLERGENS; ANAPHYLAXIS; ASTHMA; CHILD; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; VIRAL PROTEINS;

EID: 77951014482     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328335ce60     Document Type: Review

References (38)

1. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics 2009; 123 (Suppl. 3):S131-S145.
2. National Heart L, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, Summary Report 2007. J Allergy Clin Immunol 2007; 120:S93-S138.
3. Reddel HK, Ware SI, Marks GB, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353:364-369.
4. Dusser D, Montani D, Chanez P, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy 2007; 62:591-604. (Pubitemid 46763450)
5. Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32:545-554.
6. Reddel HK, Taylor DR, Bateman ED, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
7. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005; 115:132-138.
8. Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007; 119:314-321. (Pubitemid 46204808)
9. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006; 61:376-382. (Pubitemid 43723318)
10. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschoolchildrenat highrisk forasthma.NEngl JMed2006;354:1985-1997.
11. CAMP. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med2000; 343:1054-1063.
12. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372:1065-1072.
13. Gruchalla RS, Sampson HA, Matsui E, et al. Asthma morbidity among innercity adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol 2009; 124:213-221.
14. Swern AS, Tozzi CA, Knorr B, Bisgaard H. Predicting an asthma exacerbation in children 2to5 years of age. AnnAllergy,Asthma Immunol2008;101:626-630.
15. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007; 119:64-72.
16. Covar RA, Szefler SJ, Zeiger RS, et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol 2008; 122:741-747.
17. Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007; 101:481-489.
18. Haselkorn T, Robert SZ, Bradley EC, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2009; 124:921-927.
19. Haselkorn T, James EF, Robert SZ, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2009; 124:895-902.
20. Zeiger RS, Bradley EC, Tmirah H, et al. Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2009; 124:1106-1108.
21. Kwong KYC, Morphew T, Scott L, et al. Asthma control and future asthmarelated morbidity in inner-city asthmatic children. Ann Allergy, Asthma Immunol 2008; 101:144-152.
22. Cabral AL, Vollmer WM, Barbirotto R, Martins M. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study. Ann Allergy, Asthma Immunol 2009; 103:206-211.
23. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW, on behalf of the SIG. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009; 179:19-24.
24. Hunninghake GM, Soto-Quiró s ME, Avila L, et al. Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol 2007; 120:84-90. (Pubitemid 46990504)
25. Tantisira KG, Silverman ES, Mariani TJ, et al. FCER2: A pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 2007; 120:1285-1291.
26. Bisgaard H, Bonnelykke K, Sleiman PMA, et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med 2009; 179:179-185.
27. Bacharier LB, Phillips BR, Zeiger RS, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008; 122: 1127-1135.
28. Ducharme FM, Lemire C, Noya FJD, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009; 360:339-353.
29. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc 2009; 6:256-259.
30. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-984.
31. Boyd M, Lasserson T, McKean M, et al. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev 2009; (2):CD001290.
32. Schatz M, Rachelefsky G, Krishnan JA. Follow-up after acute asthma episodes: what improves future outcomes? J Allergy Clin Immunol 2009; 124 (2, Suppl. 1):S35-S42.
33. Watson WTA, Gillespie C, Thomas N, et al. Small-group, interactive education and the effect on asthma control by children and their families. CMAJ 2009; 181:257-263.
34. Cabana MDB, D, Bratton SL, Kemper AR, Clark NM. Association between outpatient follow-up and pediatric emergency department asthma visits. J Asthma 2003; 40:741-749. (Pubitemid 37377411)
35. Zorc JJ, Chew A, Allen JL, Shaw K. Beliefs and barriers to follow-up after an emergency department asthma visit: a randomized trial. Pediatrics 2009; 124:1135-1142.
36. Mansour ME. How do we support follow-up with the primary care provider after an emergency department visit for asthma? Pediatrics 2009; 124: 1206-1207.
37. Camargo CA Jr, Rachelefsky G, Schatz M. Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 Guidelines for the Management of Asthma Exacerbations. J Emerg Med 2009; 37 (2, Suppl. 1):S6-S17.
38. Martinez FD. Managing childhood asthma: challenge of preventing exacerbations. Pediatrics 2009; 123 (Suppl. 3):S146-S150.